Literature DB >> 23237313

Ventral tegmental area cannabinoid type-1 receptors control voluntary exercise performance.

Sarah Dubreucq1, Audrey Durand, Isabelle Matias, Giovanni Bénard, Elodie Richard, Edgar Soria-Gomez, Christelle Glangetas, Laurent Groc, Aya Wadleigh, Federico Massa, Dusan Bartsch, Giovanni Marsicano, Francois Georges, Francis Chaouloff.   

Abstract

BACKGROUND: We have shown that the endogenous stimulation of cannabinoid type-1 (CB₁) receptors is a prerequisite for voluntary running in mice, but the precise mechanisms through which the endocannabinoid system exerts a tonic control on running performance remain unknown.
METHODS: We analyzed the respective impacts of constitutive/conditional CB₁ receptor mutations and of CB₁ receptor blockade on wheel-running performance. We then assessed the consequences of ventral tegmental area (VTA) CB₁ receptor blockade on the wheel-running performances of wildtype (gamma-aminobutyric acid [GABA]-CB₁⁺/⁺) and mutant (GABA-CB₁⁻/⁻) mice for CB₁ receptors in brain GABA neurons. Using in vivo electrophysiology, the consequences of wheel running on VTA dopamine (DA) neuronal activity were examined in GABA-CB₁⁺/⁺ and GABA-CB₁⁻/⁻ mice.
RESULTS: Conditional deletion of CB₁ receptors from brain GABA neurons, but not from several other neuronal populations or from astrocytes, decreased wheel-running performance in mice. The inhibitory consequences of either the systemic or the intra-VTA administration of CB1 receptor antagonists on running behavior were abolished in GABA-CB₁⁻/⁻ mice. The absence of CB1 receptors from GABAergic neurons led to a depression of VTA DA neuronal activity after acute/repeated wheel running.
CONCLUSIONS: This study provides evidence that CB₁ receptors on VTA GABAergic terminals exert a permissive control on rodent voluntary running performance. Furthermore, it is shown that CB₁ receptors located on GABAergic neurons impede negative consequences of voluntary exercise on VTA DA neuronal activity. These results position the endocannabinoid control of inhibitory transmission as a prerequisite for wheel-running performance in mice.
Copyright © 2013 Society of Biological Psychiatry. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23237313     DOI: 10.1016/j.biopsych.2012.10.025

Source DB:  PubMed          Journal:  Biol Psychiatry        ISSN: 0006-3223            Impact factor:   13.382


  30 in total

1.  Activation of cannabinoid system in anterior cingulate cortex and orbitofrontal cortex modulates cost-benefit decision making.

Authors:  Abbas Khani; Mojtaba Kermani; Soghra Hesam; Abbas Haghparast; Enrike G Argandoña; Gregor Rainer
Journal:  Psychopharmacology (Berl)       Date:  2014-12-23       Impact factor: 4.530

2.  Cannabis and Exercise Science: A Commentary on Existing Studies and Suggestions for Future Directions.

Authors:  Arielle S Gillman; Kent E Hutchison; Angela D Bryan
Journal:  Sports Med       Date:  2015-10       Impact factor: 11.136

3.  The motivation for exercise over palatable food is dictated by cannabinoid type-1 receptors.

Authors:  Edgar Soria-Gomez; Carolina Muguruza; Bastien Redon; Giulia R Fois; Imane Hurel; Amandine Scocard; Claire Nguyen; Christopher Stevens; Marjorie Varilh; Astrid Cannich; Justine Daniault; Arnau Busquets-Garcia; Teresa Pelliccia; Stéphanie Caillé; François Georges; Giovanni Marsicano; Francis Chaouloff
Journal:  JCI Insight       Date:  2019-03-07

4.  GABAergic Neurons of the Central Amygdala Promote Cataplexy.

Authors:  Carrie E Mahoney; Lindsay J Agostinelli; Jessica N K Brooks; Bradford B Lowell; Thomas E Scammell
Journal:  J Neurosci       Date:  2017-02-24       Impact factor: 6.167

Review 5.  Brain cannabinoid receptor 2: expression, function and modulation.

Authors:  De-Jie Chen; Ming Gao; Fen-Fei Gao; Quan-Xi Su; Jie Wu
Journal:  Acta Pharmacol Sin       Date:  2017-01-09       Impact factor: 6.150

6.  Differential skeletal muscle proteome of high- and low-active mice.

Authors:  David P Ferguson; Lawrence J Dangott; Emily E Schmitt; Heather L Vellers; J Timothy Lightfoot
Journal:  J Appl Physiol (1985)       Date:  2014-02-06

Review 7.  Physical activity and the endocannabinoid system: an overview.

Authors:  Mirko Tantimonaco; Roberta Ceci; Stefania Sabatini; Maria Valeria Catani; Antonello Rossi; Valeria Gasperi; Mauro Maccarrone
Journal:  Cell Mol Life Sci       Date:  2014-02-14       Impact factor: 9.261

8.  A runner's high depends on cannabinoid receptors in mice.

Authors:  Johannes Fuss; Jörg Steinle; Laura Bindila; Matthias K Auer; Hartmut Kirchherr; Beat Lutz; Peter Gass
Journal:  Proc Natl Acad Sci U S A       Date:  2015-10-05       Impact factor: 11.205

Review 9.  Targeting the endocannabinoid system: a predictive, preventive, and personalized medicine-directed approach to the management of brain pathologies.

Authors:  Vamsi Reddy; Dayton Grogan; Meenakshi Ahluwalia; Évila Lopes Salles; Pankaj Ahluwalia; Hesam Khodadadi; Katelyn Alverson; Andy Nguyen; Srikrishnan P Raju; Pankaj Gaur; Molly Braun; Fernando L Vale; Vincenzo Costigliola; Krishnan Dhandapani; Babak Baban; Kumar Vaibhav
Journal:  EPMA J       Date:  2020-04-15       Impact factor: 6.543

10.  Differential Control of Cocaine Self-Administration by GABAergic and Glutamatergic CB1 Cannabinoid Receptors.

Authors:  Elena Martín-García; Lucie Bourgoin; Adeline Cathala; Fernando Kasanetz; Miguel Mondesir; Ana Gutiérrez-Rodriguez; Leire Reguero; Jean-François Fiancette; Pedro Grandes; Umberto Spampinato; Rafael Maldonado; Pier Vincenzo Piazza; Giovanni Marsicano; Véronique Deroche-Gamonet
Journal:  Neuropsychopharmacology       Date:  2015-11-27       Impact factor: 7.853

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.